Works matching IS 07423071 AND DT 2018 AND VI 35 AND IP 10


Results: 26
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Editorial Board.

    Published in:
    Diabetic Medicine, 2018, v. 35, n. 10, p. 1305, doi. 10.1111/dme.13497
    Publication type:
    Article
    19
    20

    Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

    Published in:
    Diabetic Medicine, 2018, v. 35, n. 10, p. 1375, doi. 10.1111/dme.13669
    By:
    • Tofte, N.;
    • Lindhardt, M.;
    • Frimodt‐Møller, M.;
    • Persson, F.;
    • Rossing, P.;
    • Dimos, I.;
    • Francová, L.;
    • Rychlík, I.;
    • Girman, P.;
    • Havrdova, T.;
    • Göke, R.;
    • Kooy, A.;
    • Mischak, H.;
    • Navis, G.;
    • Nijpels, G.;
    • Noutsou, M.;
    • Ortiz, A.;
    • Adamova, K.;
    • Parvanova, A.;
    • Ruggenenti, P. L.
    Publication type:
    Article
    21
    22
    23
    24

    Aims and Scope.

    Published in:
    Diabetic Medicine, 2018, v. 35, n. 10, p. 1304, doi. 10.1111/dme.13496
    Publication type:
    Article
    25
    26